UICC partner updates
UICC is proud to work with a variety of partners who share its mission to reduce the global cancer burden. To learn more about how UICC works with partners contact partnerships@uicc.org.
Partner updates
UICC extends its heartfelt gratitude to all partners and sponsors who joined the UICC community at this year’s World Cancer Leaders’ Summit. This landmark event brought together more than 400 healthcare professionals, cancer advocates, and government representatives from 55 countries in Melbourne, united in their commitment to tackling the most pressing challenges in cancer prevention, diagnostics, and treatment. Together, participants explored actionable solutions to close critical gaps and drive meaningful progress for more equitable access to cancer services globally.
These engagements reflect UICC’s ongoing commitment to fostering meaningful partnerships that drive progress in cancer control. Thank you to all UICC partners for their continued collaboration and UICC looks forward to building on this momentum in the months ahead.
Sponsors played an active role at the World Cancer Leaders’ Summit, contributing to more than 15 sponsored sessions that spanned a wide range of topics – from AI in cancer prevention, treatment, and diagnosis and actionable policies for advancing NCD and cancer targets, to patient navigation and pioneering approaches in the early detection and treatment of melanoma. These sessions allowed participants to exchange knowledge, highlighted innovative solutions, and fostered meaningful dialogue among global leaders and industry stakeholders, ensuring a rich diversity of perspectives throughout the event.
In addition, UICC partners and Summit sponsors were invited to an exclusive networking coffee morning, hosted by UICC CEO Cary Adams and UICC President Ulrika Årehed Kågström, providing further opportunities for participants to connect.
“We are sincerely grateful to our hosts, co-hosts, and partners, for making this year’s World Cancer Leaders’ Summit possible. The active engagement and leadership of all those who joined us in Melbourne made it particularly meaningful, as it marks a milestone with the release of the World Cancer Declaration. We hope the experience offered valuable opportunities for dialogue, networking and exchange.”
– Cary Adams, CEO of UICC
The next World Cancer Leaders’ Summit will be held in Nairobi, Kenya, 24-28 November 2027. UICC will be convening the global cancer community again next year in Hong Kong, 22-24 September, at the World Cancer Congress. For more information on sponsorship opportunities please contact partnerships@uicc.org.
World Cancer Day
World Cancer Day 2026 will take place on February 4 and UICC is encouraging its partners to get involved with the campaign and amplify the theme of “United by Unique”.
United by Unique places people at the centre of care and explores new ways of making a difference. Companies and employees can engage by:
-
Using World Cancer Day materials to show your support
This World Cancer Day, let's come together to rewrite the future of cancer care - one where the needs of people and communities come first.
Thank you to our World Cancer Day partners:
Visionary
AbbVie, Boehringer Ingelheim, Fujifilm, La Roche Posay, MSD, Roche
Growth
Amgen, Genmab, Jazz Pharmaceuticals, Novo Nordisk, Ono Pharma, Sanofi
For more information about joining as a World Cancer Day partner please contact partnerships@uicc.org
UICC and Roche
Testimonial from Sebastian Arias, Global Policy Leader at Roche
Roche Pharmaceuticals has been a long-standing partner of UICC since 2011, contributing to numerous cancer-related workstreams. When the ATOM Coalition launched in 2022, Roche was among the first seed funders. In parallel, we collaborated on women’s health challenges and, in 2024, collaborated on the publication: “Integrated Approaches for Women’s Cancers”.
Roche affiliates actively engage at country level, amplifying impact which is seen through the support of the Patient Group Mentoring programme which delivers tangible benefits to local communities by building capacity, strengthening cancer advocacy, and driving policy outcomes in diverse local contexts. Additionally, hosting sessions on key NCD topics during UICC’s global convening events provides the private sector with vital platforms to showcase innovation and research progress in cancer treatment.
In 2025, Roche facilitated connections with EFPIA (European Federation of Pharmaceutical Industries Associations) to sponsor the inaugural Cancer Planners Forum. Strengthening health systems remains a core priority for UICC, and cancer control plans are integral to Roche’s advocacy and policy agenda.
Finally, World Cancer Day plays a pivotal role in raising awareness of the global cancer burden - from prevention and early detection to diagnosis, treatment, and supportive care. As a proud sponsor, Roche integrates this campaign into its annual communications strategy, sharing impactful messages and real stories that champion holistic approaches to improving global cancer care.
UICC would like to thank Roche for its continued support.
Our partners' expertise and engagement are fundamental to driving long-term and measurable changes in cancer control.
Our partners
Becoming a UICC partner is a valuable opportunity for an organisation to expand its global impact on cancer control and to address Sustainable Development Goal 3, to “ensure healthy lives and promote well-being for all at all ages”.
Become a partner
UICC’s three global events offer a unique opportunity to engage with a global audience, strengthen networks and show commitment to reducing the global cancer burden.
Event sponsorship opportunities
Last update
Thursday 04 December 2025